Analysts Issue Forecasts for Appili Therapeutics Inc.'s FY2023 Earnings (TSE:APL)
Analysts Issue Forecasts for Appili Therapeutics Inc.'s FY2023 Earnings (TSE:APL)
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Stock analysts at Zacks Small Cap issued their FY2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a report released on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings of ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.
Appili治療公司(多倫多證券交易所股票代碼：APL-GET評級)--Zack Small Cap的股票分析師在7月14日星期四發佈的一份報告中發佈了他們對Appili治療公司股票2023財年每股收益(EPS)的估計。Zack Small Cap分析師D·鮑茨預計，該公司今年的每股收益將達到0.10美元。扎克斯小盤股還發布了對Appili Treateutics 2024財年每股收益(0.07美元)和2025財年每股收益(0.06美元)的估計。
Appili Therapeutics Price Performance
阿普利治療公司性價比
Read More
閲讀更多內容
- Is it Time to Cash Out Novavax Stock?
- Should you buy Bank of America Stock After Its Q2 Earnings Report?
- Monthly Dividend Stocks Can Provide Solid Income
- AMC Entertainment Is On Track For Blockbuster Results
- Why Did State Street's Stock Rally Despite Weaker Earnings?
- 是時候套現Novavax股票了嗎？
- 在美國銀行第二季度收益報告公佈後，你應該買入它的股票嗎？
- 每月分紅股票可以提供穩定的收入
- AMC娛樂公司有望獲得百視達業績
- 為什麼道富銀行的股票在盈利疲軟的情況下仍出現反彈？
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
獲得《阿普利治療日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Appili Treateutics和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。